Alar Pharmaceuticals Inc. (6785 TT) is a new 505 (b) (2) drug development company focused on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorders, chronic pains, and major depressive disorders. Take me to the website. HEADQUARTER.

CDF reports March after-tax profit of NT$3.57 billion After-tax profit for the first quarter reached NT$9.67 billion, and EPS stood at NT$0.58. China Development Financial Holding Corporation (hereinafter referred to as "CDF") reported today its profit for the month of March.

CDIB Capital Healthcare Ventures II led the series B funding round for Acepodia and helped the company successfully raise US$47 million in a very short period of time. Professional Capital Market Experience. Even during phases of market volatility, our vast resources and experience in the capital market get our partners results. ...

With an industry-leading international team, we play a pivotal leading role in Taiwan's venture capital and private equity market. Our Leadership Team. ... President, CDIB Capital Healthcare Ventures. Robert Liu Robert Liu. Managing Director, CDIB YIDA Healthcare Fund. Yen Lu Yen Lu. President, CDIB Yida Private Equity (Kunshan) Co. Ltd.

China Development Industrial Bank was officially renamed CDIB Capital Group with this underlying business transformation in March 2017. This evolution is underpinned by the goal of becoming the leading private equity and venture capital fund manager in the Asia-Pacific region. Advocate of Responsible Investing Evolving into Impact Investing.

Thanks to the investment from CDIB Capital Innovation Accelerator, FunNow has magnified its scale, bolstered its internationalization efforts, and demonstrated multiple valuation growth. /en/what-we-do/funnow

President of CDIB Capital Healthcare Ventures & CDIB Capital Healthcare Ventures II. Acting president participating in fund establishments since 2012, in charge of planning, constructing and managing fund portfolios. Director/ supervisor at Taiwanese firms TWi, CCSB, Sharehope, Synermore, Axiomtek, and RT-Mart before.

Chair, Regional Healthcare Practice Chairman, CDIB Capital Healthcare Ventures Head, CDIB Capital Healthcare Ventures II L.P. Achievements. Mr. Ho has almost 30 years of experience in industrial policy, VC investment and executive management. Serving as Deputy Executive Secretary of the Executive Yuan’s Development Fund (later renamed the ...

Venture capital and private equity investments in life sciences and healthcare in the Asia-Pacific region (Johnson & Johnson Development Corporation (JJDC)) 2013-19. Joined CDIB in 2019. Expertise in M&A and Investment Transactions

Ms. Lin spearheaded fundraising for and the establishment of CDIB Capital Growth Partners L.P., the first Taiwanese VC fund structured as a limited partnership, in 2018 with a fund value of NT$4.54bn. ... MEET OUR PRESIDENT OF CDIB CAPITAL HEALTHCARE VENTURES. Ta-Cheng Hsu. This website uses cookies to offer you the best services. By continuing ...